Is CLOV Worth Buying in 2026?

Clover Health Investments, Corp

STOCK HOSPITAL & MEDICAL SERVICE PLANS Updated 2026-06-07

Here’s whether Clover Health Investments, Corp (CLOV) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+15.90% over 10 days); RSI 59 — healthy momentum range; strong 1-year return of +26.8%; 3-month momentum positive (+91.5%). Currently 9.5% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

CLOV is in a confirmed uptrend, trading above both its 50-day ($2.77) and 200-day ($2.62) moving averages. An RSI of 58.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +26.8% compares to +24.4% for SPY (beat the market by 2.5%).

$10,000 invested 1 year ago → $12,682 today
vs. S&P 500 (SPY) — same period beat market by 2.5%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($2.62)
Above 50-day MA ($2.77)
RSI(14) neutral zone (30–70) — currently 58.8
Positive return (+26.8%)
Within 10% of period high (−9.5%)
Period Range $3.83
$1.58 $4.23
RSI (14) 58.8
0 · OversoldOverbought · 100

Key Metrics

Price$3.83
Period Return+26.8%
Period High$4.23
Period Low$1.58
Drawdown−9.5%
MA-50$2.77
MA-200$2.62
RSI (14)58.8
Avg Volume (30d)7.5M
vs. SPYbeat by 2.5%
Return Rank#499 of 1245

Trade CLOV

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers